Kevin Callerame, MD
Neurology · Baton Rouge, LANPI 1245229459
Payments from drug & device makers
Across 2,522 payments — averaging $166.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$336K
- SK Life Science, Inc.$26K
- Eisai Inc.$8K
- UCB, Inc.$8K
- Sanofi$7K
- Amylyx Pharmaceuticals, Inc.$4K
- plus $30K from 54 others
What the payments were for
- Consulting fees$6,5652%
- Speaking & faculty fees$365,86687%
- Travel & lodging$5,9081%
- Food & beverage$40,99110%
- Education$4410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$419,770 in reported general payments places this provider in the 95th percentile of 225 neurology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 116 | $1,709,442 |
| PanzygaImmun Glob G(Igg)-Ifas/Glycine | 34 | $1,312,098 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 22 | $629,453 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 14 | $489,215 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 16 | $328,821 |
| RelyvrioSod Phenylbutyrat/Taurursodiol | 20 | $248,413 |
| UbrelvyUbrogepant | 176 | $243,671 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 36 | $235,164 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 21 | $216,013 |
| QuliptaAtogepant | 141 | $164,821 |
| RadicavaEdaravone | 12 | $151,790 |
| Kesimpta PenOfatumumab | 16 | $137,673 |
| NuplazidPimavanserin Tartrate | 19 | $101,039 |
| OnfiClobazam | 25 | $100,102 |
| FycompaPerampanel | 70 | $91,324 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPanzyga, Octagam, Nurtec Odt, Lyrica, Dilantin | $1,535 | $2,038,735190 claims |
| AbbVieUbrelvy, Qulipta | $336,498 | $408,492317 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $1,037 | $328,82116 claims |
| Amylyx Pharmaceuticals, Inc.Relyvrio | $3,662 | $248,41320 claims |
| Grifols USA, LLCGamunex-C | $626 | $235,16436 claims |
| UCB, Inc.Briviact, Nayzilam | $7,980 | $116,06681 claims |
| Acadia Pharmaceuticals IncNuplazid | $1,615 | $101,03919 claims |
| Lundbeck LLCOnfi | $1,441 | $100,10225 claims |
| Eisai Inc.Fycompa | $8,120 | $91,32470 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $468 | $79,54251 claims |
| SK Life Science, Inc.Xcopri | $25,579 | $68,30545 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $3,020 | $55,48735 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 225 neurology providers in Louisiana.
Other neurology in Baton Rouge
- Jon OlsonBaton Rouge$1.7M
- Gerald CaleganBaton Rouge$400K
- Benjamin KidderBaton Rouge$35K
- Joseph AcostaBaton Rouge$33K
- William GladneyBaton Rouge$19K
- David GlossBaton Rouge$15K
- Ariel Antezana AntezanaAlexandria$2.5M
- Bridget BagertNew Orleans$1.4M
- Carol RedillasChalmette$1.3M
- Joseph TarsiaNew Orleans$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.